Corporate
Almirall appoints a new Managing Director of its market company in Poland
Barcelona, 30 June 2009.- Almirall announces the appointment of Artur Smiarowski as General Manager Poland. Through this appointment Almirall strengthens its directorship team at international level and consolidates its structure aimed at enhancing availability of its therapeutic solutions to the Polish society.
Artur Smiarowski has a degree from the Life Science University in Warsaw and an MBA from the Kozminski University in Warsaw.
Over the last few years Artur Smiarowski has held various positions within marketing and business management in pharmaceutical companies such as Roche, Schering-Plough and Blau Farma. From 2006 he held the position Business Unit Manager at Wyeth Poland.
About Almirall
Almirall is an international pharmaceutical company based on innovation and committed to health. Headquartered in Barcelona, Spain, Almirall researches, develops, manufactures and commercialises its own R&D and licensed drugs with the aim of improving people’s health and wellbeing.
The therapeutic areas on which Almirall focuses its research resources are related to the treatment of asthma, COPD (Chronic Obstructive Pulmonary Disease), rheumatoid arthritis, multiple sclerosis, psoriasis and other dermatology indications.
Almirall is currently present in over 70 countries with direct presence in Europe and Latin America through 11 affiliates.
More information:
Ketchum/SEIS
Sonia San Segundo / Patricia Mansilla
Tel.: 00 34 91 788 32 00
Press release